Characteristics, Prevention, and Management of Hepatitis B Virus (HBV) Reactivation in HBV-Infected Patients Who Require Immunosuppressive Therapy.

Genetic-based Risk Assessment for Hepatocellular Carcinoma in Patients with Hepatitis C: Where Do We Stand?

High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B.

Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus-endemic population.

Lamivudine: fading into the mists of time.

Monotherapy with tenofovir disoproxil fumarate for multiple drug-resistant chronic hepatitis B: 3-year trial.
Reply.

Risks versus Benefits of Anticoagulation for Atrial Fibrillation in Cirrhotic Patients